Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Stem Cell Transplant Failure”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00618969
What this trial is testing

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

Who this might be right for
Hematologic NeoplasmsAnemia, AplasticHemoglobinuria, Paroxysmal+1 more
University of Arizona 2
Not applicableLooking for participantsNCT06650553
What this trial is testing

Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

Who this might be right for
Aplastic Anemias
Shanxi Bethune Hospital 110
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Not applicableEnded earlyNCT01135355
What this trial is testing

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

Who this might be right for
Blood Stem Cell Transplant Failure
Stanford University 26
Not applicableStudy completedNCT06080490
What this trial is testing

Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

Who this might be right for
Graft Vs Host DiseaseTransplant FailureStem Cell Transplant Complications
University of Pisa 125
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Early research (Phase 1)UnknownNCT00005896
What this trial is testing

Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia

Who this might be right for
Fanconi's Anemia
University of Minnesota 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT01966367
What this trial is testing

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeSevere Aplastic AnemiaSevere Congenital Neutropenia+13 more
Diane George 37
Not applicableStudy completedNCT01174277
What this trial is testing

Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

Who this might be right for
Blood Stem Cell Transplant FailureGraft Versus Host Disease
University of Kansas Medical Center 23
Early research (Phase 1)UnknownNCT01165762
What this trial is testing

Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.

Who this might be right for
ESRD
Everett Meyer 25
Large-scale testing (Phase 3)Study completedNCT05466201
What this trial is testing

The Use of Eltrombopag Post HSCT in BMFD

Who this might be right for
Stem Cell Transplant Complications
The First Affiliated Hospital of Soochow University 118
Early research (Phase 1)Study completedNCT04473911
What this trial is testing

Haplo Peripheral Blood Sct In GVHD Prevention

Who this might be right for
GVHDAMLALL+13 more
Zachariah Michael DeFilipp 25
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00636909
What this trial is testing

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more
Beth Israel Deaconess Medical Center 25
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Testing effectiveness (Phase 2)Study completedNCT00919503
What this trial is testing

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Who this might be right for
Non-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 98
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660783
What this trial is testing

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureHemoglobinopathiesPrimary Immune Deficiency (PID)+4 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01760655
What this trial is testing

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62
Next Page